New leukemia immune profiles predict drug resistance, positive responses to immunotherapy

New leukemia immune profiles predict drug resistance, positive responses to immunotherapy

New leukemia immune profiles predict drug resistance, positive responses to immunotherapy

By analyzing 442 samples from three groups of children and adults with acute myeloid leukemia (AML), researchers have identified new immune classes of the disease that predict the likelihood of drug resistance and positive responses to immunotherapy.